Device
3D OCT-1 Maestro
3D OCT-1 Maestro is a medical device with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)
Phase Distribution
No phase data available
Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completed
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
NCT02447133
completed
Triton Agreement and Precision Study
NCT03080714
completed
Maestro Agreement and Precision Study II
NCT02376868
completed
Topcon 3D OCT-1 Maestro Reference Database Study II
NCT02447120
completed
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
NCT02982174
Clinical Trials (5)
Showing 5 of 5 trials
NCT02447133
TopQ Cut-off Score Validation Study for 3D OCT-1 Maestro
NCT03080714
Triton Agreement and Precision Study
NCT02376868
Maestro Agreement and Precision Study II
NCT02447120
Topcon 3D OCT-1 Maestro Reference Database Study II
NCT02982174
Evaluation of the Signal to Noise Ratio at Various Retinal Layers
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5